Drug Firms Win Parallel Trade Battle--But Not War
Executive Summary
The European Court of Justice has ruled that Bayer's actions to limit supplies of heart drug Adalat to Spanish and French wholesalers during the 90s were legal. Although the long-awaited decision is case-specific, it sets a useful legal precedent for other manufacturers seeking to stem parallel trade, particularly as EU enlargement approaches.